Interaction between the microbiome and TP53 in human lung cancer
Abstract Background Lung cancer is the leading cancer diagnosis worldwide and the number one cause of cancer deaths. Exposure to cigarette smoke, the primary risk factor in lung cancer, reduces epithelial barrier integrity and increases susceptibility to infections. Herein, we hypothesize that somat...
Main Authors: | , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , |
---|---|
Format: | Article |
Language: | English |
Published: |
BMC
2018-08-01
|
Series: | Genome Biology |
Subjects: | |
Online Access: | http://link.springer.com/article/10.1186/s13059-018-1501-6 |
id |
doaj-c60baebde4ef47978781cd73c5e4c2ee |
---|---|
record_format |
Article |
collection |
DOAJ |
language |
English |
format |
Article |
sources |
DOAJ |
author |
K. Leigh Greathouse James R. White Ashely J. Vargas Valery V. Bliskovsky Jessica A. Beck Natalia von Muhlinen Eric C. Polley Elise D. Bowman Mohammed A. Khan Ana I. Robles Tomer Cooks Bríd M. Ryan Noah Padgett Amiran H. Dzutsev Giorgio Trinchieri Marbin A. Pineda Sven Bilke Paul S. Meltzer Alexis N. Hokenstad Tricia M. Stickrod Marina R. Walther-Antonio Joshua P. Earl Joshua C. Mell Jaroslaw E. Krol Sergey V. Balashov Archana S. Bhat Garth D. Ehrlich Alex Valm Clayton Deming Sean Conlan Julia Oh Julie A. Segre Curtis C. Harris |
spellingShingle |
K. Leigh Greathouse James R. White Ashely J. Vargas Valery V. Bliskovsky Jessica A. Beck Natalia von Muhlinen Eric C. Polley Elise D. Bowman Mohammed A. Khan Ana I. Robles Tomer Cooks Bríd M. Ryan Noah Padgett Amiran H. Dzutsev Giorgio Trinchieri Marbin A. Pineda Sven Bilke Paul S. Meltzer Alexis N. Hokenstad Tricia M. Stickrod Marina R. Walther-Antonio Joshua P. Earl Joshua C. Mell Jaroslaw E. Krol Sergey V. Balashov Archana S. Bhat Garth D. Ehrlich Alex Valm Clayton Deming Sean Conlan Julia Oh Julie A. Segre Curtis C. Harris Interaction between the microbiome and TP53 in human lung cancer Genome Biology Lung cancer Microbiome TP53 Squamous cell carcinoma Mutation |
author_facet |
K. Leigh Greathouse James R. White Ashely J. Vargas Valery V. Bliskovsky Jessica A. Beck Natalia von Muhlinen Eric C. Polley Elise D. Bowman Mohammed A. Khan Ana I. Robles Tomer Cooks Bríd M. Ryan Noah Padgett Amiran H. Dzutsev Giorgio Trinchieri Marbin A. Pineda Sven Bilke Paul S. Meltzer Alexis N. Hokenstad Tricia M. Stickrod Marina R. Walther-Antonio Joshua P. Earl Joshua C. Mell Jaroslaw E. Krol Sergey V. Balashov Archana S. Bhat Garth D. Ehrlich Alex Valm Clayton Deming Sean Conlan Julia Oh Julie A. Segre Curtis C. Harris |
author_sort |
K. Leigh Greathouse |
title |
Interaction between the microbiome and TP53 in human lung cancer |
title_short |
Interaction between the microbiome and TP53 in human lung cancer |
title_full |
Interaction between the microbiome and TP53 in human lung cancer |
title_fullStr |
Interaction between the microbiome and TP53 in human lung cancer |
title_full_unstemmed |
Interaction between the microbiome and TP53 in human lung cancer |
title_sort |
interaction between the microbiome and tp53 in human lung cancer |
publisher |
BMC |
series |
Genome Biology |
issn |
1474-760X |
publishDate |
2018-08-01 |
description |
Abstract Background Lung cancer is the leading cancer diagnosis worldwide and the number one cause of cancer deaths. Exposure to cigarette smoke, the primary risk factor in lung cancer, reduces epithelial barrier integrity and increases susceptibility to infections. Herein, we hypothesize that somatic mutations together with cigarette smoke generate a dysbiotic microbiota that is associated with lung carcinogenesis. Using lung tissue from 33 controls and 143 cancer cases, we conduct 16S ribosomal RNA (rRNA) bacterial gene sequencing, with RNA-sequencing data from lung cancer cases in The Cancer Genome Atlas serving as the validation cohort. Results Overall, we demonstrate a lower alpha diversity in normal lung as compared to non-tumor adjacent or tumor tissue. In squamous cell carcinoma specifically, a separate group of taxa are identified, in which Acidovorax is enriched in smokers. Acidovorax temporans is identified within tumor sections by fluorescent in situ hybridization and confirmed by two separate 16S rRNA strategies. Further, these taxa, including Acidovorax, exhibit higher abundance among the subset of squamous cell carcinoma cases with TP53 mutations, an association not seen in adenocarcinomas. Conclusions The results of this comprehensive study show both microbiome-gene and microbiome-exposure interactions in squamous cell carcinoma lung cancer tissue. Specifically, tumors harboring TP53 mutations, which can impair epithelial function, have a unique bacterial consortium that is higher in relative abundance in smoking-associated tumors of this type. Given the significant need for clinical diagnostic tools in lung cancer, this study may provide novel biomarkers for early detection. |
topic |
Lung cancer Microbiome TP53 Squamous cell carcinoma Mutation |
url |
http://link.springer.com/article/10.1186/s13059-018-1501-6 |
work_keys_str_mv |
AT kleighgreathouse interactionbetweenthemicrobiomeandtp53inhumanlungcancer AT jamesrwhite interactionbetweenthemicrobiomeandtp53inhumanlungcancer AT ashelyjvargas interactionbetweenthemicrobiomeandtp53inhumanlungcancer AT valeryvbliskovsky interactionbetweenthemicrobiomeandtp53inhumanlungcancer AT jessicaabeck interactionbetweenthemicrobiomeandtp53inhumanlungcancer AT nataliavonmuhlinen interactionbetweenthemicrobiomeandtp53inhumanlungcancer AT ericcpolley interactionbetweenthemicrobiomeandtp53inhumanlungcancer AT elisedbowman interactionbetweenthemicrobiomeandtp53inhumanlungcancer AT mohammedakhan interactionbetweenthemicrobiomeandtp53inhumanlungcancer AT anairobles interactionbetweenthemicrobiomeandtp53inhumanlungcancer AT tomercooks interactionbetweenthemicrobiomeandtp53inhumanlungcancer AT bridmryan interactionbetweenthemicrobiomeandtp53inhumanlungcancer AT noahpadgett interactionbetweenthemicrobiomeandtp53inhumanlungcancer AT amiranhdzutsev interactionbetweenthemicrobiomeandtp53inhumanlungcancer AT giorgiotrinchieri interactionbetweenthemicrobiomeandtp53inhumanlungcancer AT marbinapineda interactionbetweenthemicrobiomeandtp53inhumanlungcancer AT svenbilke interactionbetweenthemicrobiomeandtp53inhumanlungcancer AT paulsmeltzer interactionbetweenthemicrobiomeandtp53inhumanlungcancer AT alexisnhokenstad interactionbetweenthemicrobiomeandtp53inhumanlungcancer AT triciamstickrod interactionbetweenthemicrobiomeandtp53inhumanlungcancer AT marinarwaltherantonio interactionbetweenthemicrobiomeandtp53inhumanlungcancer AT joshuapearl interactionbetweenthemicrobiomeandtp53inhumanlungcancer AT joshuacmell interactionbetweenthemicrobiomeandtp53inhumanlungcancer AT jaroslawekrol interactionbetweenthemicrobiomeandtp53inhumanlungcancer AT sergeyvbalashov interactionbetweenthemicrobiomeandtp53inhumanlungcancer AT archanasbhat interactionbetweenthemicrobiomeandtp53inhumanlungcancer AT garthdehrlich interactionbetweenthemicrobiomeandtp53inhumanlungcancer AT alexvalm interactionbetweenthemicrobiomeandtp53inhumanlungcancer AT claytondeming interactionbetweenthemicrobiomeandtp53inhumanlungcancer AT seanconlan interactionbetweenthemicrobiomeandtp53inhumanlungcancer AT juliaoh interactionbetweenthemicrobiomeandtp53inhumanlungcancer AT julieasegre interactionbetweenthemicrobiomeandtp53inhumanlungcancer AT curtischarris interactionbetweenthemicrobiomeandtp53inhumanlungcancer |
_version_ |
1725885910106505216 |
spelling |
doaj-c60baebde4ef47978781cd73c5e4c2ee2020-11-24T21:50:00ZengBMCGenome Biology1474-760X2018-08-0119111610.1186/s13059-018-1501-6Interaction between the microbiome and TP53 in human lung cancerK. Leigh Greathouse0James R. White1Ashely J. Vargas2Valery V. Bliskovsky3Jessica A. Beck4Natalia von Muhlinen5Eric C. Polley6Elise D. Bowman7Mohammed A. Khan8Ana I. Robles9Tomer Cooks10Bríd M. Ryan11Noah Padgett12Amiran H. Dzutsev13Giorgio Trinchieri14Marbin A. Pineda15Sven Bilke16Paul S. Meltzer17Alexis N. Hokenstad18Tricia M. Stickrod19Marina R. Walther-Antonio20Joshua P. Earl21Joshua C. Mell22Jaroslaw E. Krol23Sergey V. Balashov24Archana S. Bhat25Garth D. Ehrlich26Alex Valm27Clayton Deming28Sean Conlan29Julia Oh30Julie A. Segre31Curtis C. Harris32Laboratory of Human Carcinogenesis, Center for Cancer, Research, National Cancer Institute, National Institutes of HealthResphera BiosciencesLaboratory of Human Carcinogenesis, Center for Cancer, Research, National Cancer Institute, National Institutes of HealthCenter for Cancer Research Genomics Core, National Cancer Institute, National Institutes of HealthLaboratory of Human Carcinogenesis, Center for Cancer, Research, National Cancer Institute, National Institutes of HealthLaboratory of Human Carcinogenesis, Center for Cancer, Research, National Cancer Institute, National Institutes of HealthDivision of Biomedical Statistics and Informatics, Mayo ClinicLaboratory of Human Carcinogenesis, Center for Cancer, Research, National Cancer Institute, National Institutes of HealthLaboratory of Human Carcinogenesis, Center for Cancer, Research, National Cancer Institute, National Institutes of HealthLaboratory of Human Carcinogenesis, Center for Cancer, Research, National Cancer Institute, National Institutes of HealthLaboratory of Human Carcinogenesis, Center for Cancer, Research, National Cancer Institute, National Institutes of HealthLaboratory of Human Carcinogenesis, Center for Cancer, Research, National Cancer Institute, National Institutes of HealthDepartment of Educational Psychology, Baylor UniversityLaboratory of Experimental Immunology, Center for Cancer Research, National Cancer InstituteLaboratory of Experimental Immunology, Center for Cancer Research, National Cancer InstituteGenetics Branch, Center for Cancer Research, National Cancer Institute, National Institutes of Health BethesdaGenetics Branch, Center for Cancer Research, National Cancer Institute, National Institutes of Health BethesdaGenetics Branch, Center for Cancer Research, National Cancer Institute, National Institutes of Health BethesdaDepartment of Obstetrics and Gynecology, Mayo ClinicMicrobiome Laboratory, Mayo ClinicDepartment of Obstetrics and Gynecology, Mayo ClinicDepartment of Microbiology and Immunology, Center for Genomic Sciences, Institute of Molecular Medicine and Infectious Disease, Drexel University College of MedicineDepartment of Microbiology and Immunology, Center for Genomic Sciences, Institute of Molecular Medicine and Infectious Disease, Drexel University College of MedicineDepartment of Microbiology and Immunology, Center for Genomic Sciences, Institute of Molecular Medicine and Infectious Disease, Drexel University College of MedicineDepartment of Microbiology and Immunology, Center for Genomic Sciences, Institute of Molecular Medicine and Infectious Disease, Drexel University College of MedicineDepartment of Microbiology and Immunology, Center for Genomic Sciences, Institute of Molecular Medicine and Infectious Disease, Drexel University College of MedicineDepartment of Microbiology and Immunology, Center for Genomic Sciences, Institute of Molecular Medicine and Infectious Disease, Drexel University College of MedicineNational Human Genome Research Institute, National Institutes of HealthNational Human Genome Research Institute, National Institutes of HealthNational Human Genome Research Institute, National Institutes of HealthJackson LaboratoryNational Human Genome Research Institute, National Institutes of HealthLaboratory of Human Carcinogenesis, Center for Cancer, Research, National Cancer Institute, National Institutes of HealthAbstract Background Lung cancer is the leading cancer diagnosis worldwide and the number one cause of cancer deaths. Exposure to cigarette smoke, the primary risk factor in lung cancer, reduces epithelial barrier integrity and increases susceptibility to infections. Herein, we hypothesize that somatic mutations together with cigarette smoke generate a dysbiotic microbiota that is associated with lung carcinogenesis. Using lung tissue from 33 controls and 143 cancer cases, we conduct 16S ribosomal RNA (rRNA) bacterial gene sequencing, with RNA-sequencing data from lung cancer cases in The Cancer Genome Atlas serving as the validation cohort. Results Overall, we demonstrate a lower alpha diversity in normal lung as compared to non-tumor adjacent or tumor tissue. In squamous cell carcinoma specifically, a separate group of taxa are identified, in which Acidovorax is enriched in smokers. Acidovorax temporans is identified within tumor sections by fluorescent in situ hybridization and confirmed by two separate 16S rRNA strategies. Further, these taxa, including Acidovorax, exhibit higher abundance among the subset of squamous cell carcinoma cases with TP53 mutations, an association not seen in adenocarcinomas. Conclusions The results of this comprehensive study show both microbiome-gene and microbiome-exposure interactions in squamous cell carcinoma lung cancer tissue. Specifically, tumors harboring TP53 mutations, which can impair epithelial function, have a unique bacterial consortium that is higher in relative abundance in smoking-associated tumors of this type. Given the significant need for clinical diagnostic tools in lung cancer, this study may provide novel biomarkers for early detection.http://link.springer.com/article/10.1186/s13059-018-1501-6Lung cancerMicrobiomeTP53Squamous cell carcinomaMutation |